Deborah Morosini

EVP, Chief of Clinical Affairs, Prelude Therapeutics Inc.

Companies

Prelude Therapeutics IncEVP, Chief of Clinical Affairs Sep 24, 2020 to Feb 17, 2022¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Prelude Therapeutics Inc PRLD444 shares²$1.5K at $3.37Dec 15, 2021

As of each latest filing. The line shows shares held over time.

Recent filings

Dec 15, 2021Sold 28,751 shares at $13.00 of Prelude Therapeutics Inc²
Dec 15, 2021Exercised options 25,735 shares at $12.85 of Prelude Therapeutics Inc²
Dec 15, 2021Exercised options 3,016 shares at $1.89 of Prelude Therapeutics Inc²
Nov 16, 2021Sold 400 shares at $16.43 of Prelude Therapeutics Inc³
Nov 16, 2021Sold 28,351 shares at $15.87 of Prelude Therapeutics Inc³
Nov 16, 2021Exercised options 28,751 shares at $12.85 of Prelude Therapeutics Inc³

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARPrelude Therapeutics Inc, EVP, Chief of Clinical Affairs
2
SEC EDGARPrelude Therapeutics Inc shares after the filing of Dec 15, 2021
3
SEC EDGARForm 4 filed Nov 18, 2021